Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2022 | Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations | HSIN-YUN SUN ; Chiang, Chieh; Huang, Sung-Hsi; Guo, Wen-Jin; YU-CHUNG CHUANG ; YI-CHIA HUANG ; Yang, Chia-Jui; Su, Li-Hsin; YI-TING CHEN ; Chen, Yea-Wen; Hsu, Fu-Chiang; Ho, Shu-Yuan; Liu, Wen-Chun; Su, Yi-Ching; SUI-YUAN CHANG ; Hsiao, Chin-Fu; CHIEN-CHING HUNG ; Yu, Ming-Lung | Microbiology spectrum | 9 | 6 | |
2020 | Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011–2018 | Ho, Shu-Yuan; Su, Li-Hsin; HSIN-YUN SUN ; YU-SHAN HUANG ; YU-CHUNG CHUANG ; Huang, Miao-Hui; Liu, Wen-Chun; Su, Yi-Ching; Lin, Pi-Han; SUI-YUAN CHANG ; CHIEN-CHING HUNG | EClinicalMedicine | 15 | 14 | |
2018 | Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan | HSIN-YUN SUN ; Huang Y.-W.; Huang W.-C.; LIH-YU CHANG ; Chan P.-C.; YU-CHUNG CHUANG ; SHENG-YUAN RUAN ; JANN-YUAN WANG ; JANN-TAY WANG | Tuberculosis | 38 | 32 | |
2021 | Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression | Peng, An-Ting; Huang, Sung-Hsi; HSIN-YUN SUN ; YI-CHIA HUANG ; YU-CHUNG CHUANG ; Wu, Pei-Ying; Chen, Ling-Ya; Chang, Hsi-Yen; Luo, Yu-Zhen; Liu, Wen-Chun; HAN-YUEH KUO ; CHIEN-CHING HUNG | AIDS (London, England) | 2 | 1 | |
2018 | Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection | UN-IN WU ; YU-CHUNG CHUANG ; WANG-HUEI SHENG ; HSIN-YUN SUN ; Jhong, Y. T.; JANN-YUAN WANG ; SHAN-CHWEN CHANG ; JANN-TAY WANG ; YEE-CHUN CHEN | Clinical Microbiology and Infection | 43 | 42 | |
2012 | Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia | YU-CHUNG CHUANG ; SHAN-CHWEN CHANG ; Wang W.-K. | Critical Care Medicine | 27 | 25 | |
2016 | Virological response to tenofovir disoproxil fumarate in HIV-positive patients with Lamivudine-resistant hepatitis b virus coinfection in an area hyperendemic for Hepatitis B Virus Infection | YU-SHAN HUANG ; SUI-YUAN CHANG ; WANG-HUEI SHENG ; HSIN-YUN SUN ; Lee K.-Y.; YU-CHUNG CHUANG ; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | PLoS ONE | 13 | 12 | |
2022 | Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus | YU-SHAN HUANG ; HSIN-YUN SUN ; SUI-YUAN CHANG ; YU-CHUNG CHUANG ; Su, Yi-Ching; Liu, Wen-Chun; CHIEN-CHING HUNG | International journal of antimicrobial agents | 2 | 2 | |
2023 | Weight and metabolic changes among virally-suppressed people living with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide | Hsu, Jen-Yu; HSIN-YUN SUN ; Chen, Ling-Ya; SUI-YUAN CHANG ; YU-CHUNG CHUANG ; YU-SHAN HUANG ; Su, Yi-Ching; Liu, Wen-Chun; CHIEN-CHING HUNG | Journal of global antimicrobial resistance | | | |
2020 | Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Kuo P.-H.; HSIN-YUN SUN ; YU-CHUNG CHUANG ; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG | International Journal of Infectious Diseases | 36 | 40 | |